StockData
MannKind Corp logo

MannKind Corp (MNKD) stock

MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30127% above fair value
$4.07+0.12 (+2.91%)

Close on Nov 17, 2026Market cap $1.31BP/E –Yield –

MannKind price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

MannKind's price to sales ratio was 3.3× on Nov 11, 2026, against 5.2× a year earlier. Over the last 5 years it ranged from 2.2× to 18.9×, with a median of 6.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.3×−2.2
2025Dec 31, 20255.5×−1.1
2024Dec 31, 20246.6×+1.1
2023Dec 29, 20235.6×−12.6
2022Dec 30, 202218.2×+4.8
2021Dec 31, 202113.4×+1.9
2020Dec 31, 202011.5×+7.3
2019Dec 31, 20194.2×−6.1
2018Dec 31, 201810.3×−2.0
2017Dec 29, 201712.4×+10.5
2016Dec 30, 20161.9×–

More MannKind figures

See a number that looks wrong?